{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T02:02:21Z","timestamp":1784512941349,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T00:00:00Z","timestamp":1779667200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T00:00:00Z","timestamp":1784505600000},"content-version":"vor","delay-in-days":56,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/501100007941","name":"Addis Ababa University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007941","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Gastroenterol"],"DOI":"10.1186\/s12876-026-04946-8","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T10:24:59Z","timestamp":1779704699000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical profile and hepatocellular cancer treatment patterns in resource limited settings- a cross-sectional observational study at two tertiary referral teaching hospitals, Addis Ababa, Ethiopia"],"prefix":"10.1186","volume":"26","author":[{"given":"Tebarek Jemal","family":"Hassen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shimelis","family":"Nigussie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henok","family":"Teshome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henok","family":"Seife","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,25]]},"reference":[{"key":"4946_CR1","doi-asserted-by":"publisher","unstructured":"Bray F, Laversanne M, Sung H, Ferlay J, Siegel RL, Soerjomataram I, Jemal A. Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2024;74(3):229\u2013263. https:\/\/doi.org\/10.3322\/caac.21834.\u00a0Epub 2024 Apr 4. PMID: 38572751.","DOI":"10.3322\/caac.21834"},{"issue":"1","key":"4946_CR2","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1016\/j.jhep.2008.07.029","volume":"50","author":"K Lang","year":"2009","unstructured":"Lang K, Danchenko N, Gondek K, Shah S, Thompson D. The burden of illness associated with hepatocellular carcinoma in the United States. J Hepatol. 2009;50(1):89\u201399. https:\/\/doi.org\/10.1016\/j.jhep.2008.07.029 . Epub 2008 Oct 1. PMID: 18977551.","journal-title":"J Hepatol"},{"key":"4946_CR3","doi-asserted-by":"publisher","unstructured":"Singavi AK, Szabo A, Thomas JP et al. Costs of care with liver directed therapy (LDT) and sorafenib (S) in patients (pts) with hepatocellular carcinoma (HCC). J Clin Oncol Febr 2018: 36(4_suppl):383\u2013383: https:\/\/doi.org\/10.1200\/JCO.2018.36.4_suppl.383","DOI":"10.1200\/JCO.2018.36.4_suppl.383"},{"key":"4946_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.3332\/ecancer.2019.950","volume":"13","author":"P Ndom","year":"2019","unstructured":"Ndom P. Cancer prevention in Africa: liver cancer. Ecancermedicalscience. 2019;13:950. https:\/\/doi.org\/10.3332\/ecancer.2019.950 . PMID: 31552123; PMCID: PMC6722110.","journal-title":"Ecancermedicalscience"},{"issue":"2","key":"4946_CR5","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1055\/s-0039-3399566","volume":"40","author":"E Okeke","year":"2020","unstructured":"Okeke E, Davwar PM, Roberts L, Sartorius K, Spearman W, Malu A, Duguru M. Epidemiology of Liver Cancer in Africa: Current and Future Trends. Semin Liver Dis. 2020;40(2):111\u201323. https:\/\/doi.org\/10.1055\/s-0039-3399566 . Epub 2019 Nov 14. PMID: 31726474.","journal-title":"Semin Liver Dis"},{"issue":"10","key":"4946_CR6","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y . Epub 2019 Aug 22. PMID: 31439937; PMCID: PMC6813818.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"1","key":"4946_CR7","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1186\/s12889-025-22026-6","volume":"25","author":"Z Jiang","year":"2025","unstructured":"Jiang Z, Zeng G, Dai H, Bian Y, Wang L, Cao W, Yang J. Global, regional and national burden of liver cancer 1990\u20132021: a systematic analysis of the global burden of disease study 2021. BMC Public Health. 2025;25(1):931. https:\/\/doi.org\/10.1186\/s12889-025-22026-6 . PMID: 40057711; PMCID: PMC11890516.","journal-title":"BMC Public Health"},{"issue":"1","key":"4946_CR8","doi-asserted-by":"publisher","first-page":"12736","DOI":"10.1038\/s41598-022-17128-9","volume":"12","author":"AF Awedew","year":"2022","unstructured":"Awedew AF, Asefa Z, Belay WB. National Burden and Trend of Cancer in Ethiopia, 2010\u20132019: a systemic analysis for Global burden of disease study. Sci Rep. 2022;12(1):12736. https:\/\/doi.org\/10.1038\/s41598-022-17128-9 . PMID: 35882895; PMCID: PMC9325704.","journal-title":"Sci Rep"},{"key":"4946_CR9","unstructured":"Thomas London W, Petrick JL, McGlynn KA. Liver cancer. In: Thun M, Linet MS, Cerhan JR, Haiman CA, Schottenfeld D, editors. Cancer Epidemiology and Prevention. 4th ed. Oxford University Press; 2018. pp. 635\u201360."},{"issue":"2","key":"4946_CR10","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1016\/j.cld.2015.01.001","volume":"19","author":"KA McGlynn","year":"2015","unstructured":"McGlynn KA, Petrick JL, London WT. Global epidemiology of hepatocellular carcinoma: an emphasis on demographic and regional variability. Clin Liver Dis. 2015;19(2):223\u201338. https:\/\/doi.org\/10.1016\/j.cld.2015.01.001 . Epub 2015 Feb 26. PMID: 25921660; PMCID: PMC4712629.","journal-title":"Clin Liver Dis"},{"issue":"1","key":"4946_CR11","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1038\/s41392-024-02075-w","volume":"10","author":"J Zheng","year":"2025","unstructured":"Zheng J, Wang S, Xia L, Sun Z, Chan KM, Bernards R, Qin W, Chen J, Xia Q, Jin H. Hepatocellular carcinoma: signaling pathways and therapeutic advances. Signal Transduct Target Ther. 2025;10(1):35. https:\/\/doi.org\/10.1038\/s41392-024-02075-w . PMID: 39915447; PMCID: PMC11802921.","journal-title":"Signal Transduct Target Ther"},{"issue":"6","key":"4946_CR12","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1002\/cld.111","volume":"1","author":"DA Herbst","year":"2013","unstructured":"Herbst DA, Reddy KR. Risk factors for hepatocellular carcinoma. Clin Liver Dis (Hoboken). 2013;1(6):180\u20132. https:\/\/doi.org\/10.1002\/cld.111 . PMID: 31186882; PMCID: PMC6499296.","journal-title":"Clin Liver Dis (Hoboken)"},{"issue":"9","key":"4946_CR13","doi-asserted-by":"publisher","first-page":"1624","DOI":"10.1111\/liv.13888","volume":"38","author":"A Sangiovanni","year":"2018","unstructured":"Sangiovanni A, Triolo M, Iavarone M, Forzenigo LV, Nicolini A, Rossi G, et al. Multimodality treatment of hepatocellular carcinoma: How field practice complies wi th international recommendations. Liver international: official J Int Association Study Liver. 2018;38(9):1624\u201334. Epub 2018 May 24.","journal-title":"Liver international: official J Int Association Study Liver"},{"key":"4946_CR14","doi-asserted-by":"publisher","first-page":"81","DOI":"10.33590\/emjhepatol\/10311703","volume":"51","author":"L Charach","year":"2017","unstructured":"Charach L, Zusmanovitch L, Charach G, Hepatocellular Carcinoma. Part 2: Clinical Presentation and Diagnosis. Emj Hepatol. 2017;51:81\u20138.","journal-title":"Emj Hepatol"},{"key":"4946_CR15","doi-asserted-by":"publisher","unstructured":"Heimbach JK, Kulik LM, Finn RS, Sirlin CB, Abecassis MM, Roberts LR, Zhu AX, Murad MH, Marrero JA. AASLD guidelines for the treatment of hepatocellular carcinoma. Hepatology. 2018;67(1):358\u2013380. https:\/\/doi.org\/10.1002\/hep.29086. PMID: 28130846.","DOI":"10.1002\/hep.29086"},{"key":"4946_CR16","doi-asserted-by":"publisher","unstructured":"Yang JD, Mohamed EA, Aziz AO et al. Characteristics, management, and outcomes of patients with hepatocellular carcinoma in Africa: a multicountry observational study from the Africa Liver Cancer Consortium. Lancet Gastroenterol Hepatol. 2017;2(2):103\u2013111. https:\/\/doi.org\/10.1016\/S2468-1253(16)30161-3. Epub 2016 Dec 3. Erratum in: Lancet Gastroenterol Hepatol. 2022;7(8):704. https:\/\/doi.org\/10.1016\/S2468-1253(22)00208-4. PMID: 28403980.","DOI":"10.1016\/S2468-1253(16)30161-3"},{"issue":"1","key":"4946_CR17","doi-asserted-by":"publisher","first-page":"193","DOI":"10.3390\/cancers15010193","volume":"15","author":"GB Abza","year":"2022","unstructured":"Abza GB, Ahmed JH, Yesufe AA, Seife E, Erkie M, Spriet I, Chelkeba L, Annaert P. Clinicopathological Features and Survival of Patients with Hepatocellular Carcinoma in Ethiopia: A Multicenter Study. Cancers (Basel). 2022;15(1):193. https:\/\/doi.org\/10.3390\/cancers15010193 . PMID: 36612189; PMCID: PMC9818669.","journal-title":"Cancers (Basel)"},{"issue":"2","key":"4946_CR18","doi-asserted-by":"publisher","first-page":"e0627","DOI":"10.1097\/HC9.0000000000000627","volume":"9","author":"D Rayapati","year":"2025","unstructured":"Rayapati D, McGlynn KA, Groopman JD, Kim AK. Environmental exposures and the risk of hepatocellular carcinoma. Hepatol Commun. 2025;9(2):e0627. https:\/\/doi.org\/10.1097\/HC9.0000000000000627 . PMID: 39813595; PMCID: PMC11737496.","journal-title":"Hepatol Commun"},{"key":"4946_CR19","unstructured":"IARC monographs. Some naturally occurring substances: Food items and constitutents, heterocyclic aromatic amines and mycotoxins. IARC Monogr Eval Carcinog Risk Hum. 1993;56:245\u2013397."},{"issue":"14","key":"4946_CR20","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/j.ejca.2012.02.009","volume":"48","author":"Y Liu","year":"2012","unstructured":"Liu Y, Chang CC, Marsh GM, Wu F. Population attributable risk of aflatoxin-related liver cancer: Systematic review and metaanalysis. Meta-Analysis Research Support, N.I.H., Extramural Review. Eur J Cancer. 2012;48(14):2125\u201336. https:\/\/doi.org\/10.1016\/j.ejca.2012.02.009 . Epub 2012 Mar 8. PMID: 22405700; PMCID: PMC3374897.","journal-title":"Eur J Cancer"},{"key":"4946_CR21","doi-asserted-by":"publisher","unstructured":"Huang M, Chen H, Wang H, Zhang Y, Li L, Lan Y, Ma L. Global burden and risk factors of MASLD: trends from 1990 to 2021 and predictions to 2030. Intern Emerg Med. 2025;20(4):1013\u201324. https:\/\/doi.org\/10.1007\/s11739-025-03895-6. Epub 2025 Feb 28. PMID: 40019669; PMCID: PMC12130103.\u00a0","DOI":"10.1007\/s11739-025-03895-6"},{"issue":"11","key":"4946_CR22","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1016\/S2468-1253(22)00042-5","volume":"7","author":"E Jonas","year":"2022","unstructured":"Jonas E, Bernon M, Robertson B, Kassianides C, Keli E, Asare KO, Alatise IO, Okello M, Blondel NO, Mulehane KO, Abubeker ZA, Nogoud AA, Nashidengo PR, Chihaka O, Tzeuton C, Dusheiko G, Sonderup M, Spearman CW. Gastroenterology and Hepatology Association of sub-Saharan Africa (GHASSA). Treatment of hepatocellular carcinoma in sub-Saharan Africa: challenges and solutions. Lancet Gastroenterol Hepatol. 2022;7(11):1049\u201360. https:\/\/doi.org\/10.1016\/S2468-1253(22)00042-5 . Epub 2022 Jul 8. PMID: 35810767.","journal-title":"Lancet Gastroenterol Hepatol"},{"issue":"5","key":"4946_CR23","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1016\/j.hpb.2025.02.007","volume":"27","author":"E Jonas","year":"2025","unstructured":"Jonas E, Smith M, Kassianides C, Luyirika E, Wendy Spearman C. IHPBA White Paper - The improvement of management pathways and access to care in sub-Saharan Africa for patients with hepatocellular carcinoma. HPB (Oxford). 2025;27(5):585\u201390. https:\/\/doi.org\/10.1016\/j.hpb.2025.02.007.\u00a0Epub 2025 Feb 18. PMID: 40037975.","journal-title":"HPB (Oxford)"},{"issue":"10","key":"4946_CR24","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1038\/s41575-019-0186-y","volume":"16","author":"JD Yang","year":"2019","unstructured":"Yang JD, Hainaut P, Gores GJ, Amadou A, Plymoth A, Roberts LR. A global view of hepatocellular carcinoma: trends, risk, prevention and management. Nat Rev Gastroenterol Hepatol. 2019;16(10):589\u2013604. https:\/\/doi.org\/10.1038\/s41575-019-0186-y . Epub 2019 Aug 22. PMID: 31439937; PMCID: PMC6813818.","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"4946_CR25","doi-asserted-by":"publisher","unstructured":"Sel\u00e7uk H. Prognostic Factors and Staging Systems in Hepatocellular Carcinoma. Exp Clin Transplant. 2017;15(Suppl 2):45\u201349. https:\/\/doi.org\/10.6002\/ect.TOND16.L11. PMID: 28301998.","DOI":"10.6002\/ect.TOND16.L11"},{"key":"4946_CR26","doi-asserted-by":"publisher","unstructured":"Kudo M, Ueshima K, Yokosuka O et al. Sorafenib plus low-dose cisplatin and fluorouracil hepatic arterial infusion chemotherapy versus sorafenib alone in patients with advanced hepatocellular carcinoma (SILIUS): a randomised, open label, phase 3 trial. Lancet Gastroenterol Hepatol. 2018;3(6):424\u2013432. https:\/\/doi.org\/10.1016\/S2468-1253(18)30078-5. Epub 2018 Apr 7. PMID: 29631810.","DOI":"10.1016\/S2468-1253(18)30078-5"},{"key":"4946_CR27","doi-asserted-by":"publisher","unstructured":"Sim YK, Chong MC, Gandhi M, Pokharkar YM, Zhu Y, Shi L, Lequn L, Chen CH, Kudo M, Lee JH, Strasser SI, Chanwat R, Chow PKH. Asia-Pacific Hepatocellular Carcinoma Trials Group. Real-World Data on the Diagnosis, Treatment, and Management of Hepatocellular Carcinoma in the Asia-Pacific: The INSIGHT Study. Liver Cancer. 2023;13(3):298\u2013313. https:\/\/doi.org\/10.1159\/000534513. PMID: 38756144; PMCID: PMC11095624.\u00a0","DOI":"10.1159\/000534513"},{"issue":"9","key":"4946_CR28","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1111\/liv.12818","volume":"35","author":"JW Park","year":"2015","unstructured":"Park JW, Chen M, Colombo M, Roberts LR, Schwartz M, Chen PJ, Kudo M, Johnson P, Wagner S, Orsini LS, Sherman M. Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study. Liver Int. 2015;35(9):2155\u201366. https:\/\/doi.org\/10.1111\/liv.12818 . Epub 2015 Mar 25. PMID: 25752327; PMCID: PMC4691343.","journal-title":"Liver Int"},{"issue":"1","key":"4946_CR29","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.hpb.2023.09.015","volume":"26","author":"S Sobnach","year":"2024","unstructured":"Sobnach S, Kotze U, Spearman CW, Sonderup M, Nashidengo PR, Ede C, Keli E, Chihaka O, Zerbini LF, Li YJ, Gandhi K, Krige J, Jonas E. The management and outcomes of hepatocellular carcinoma in sub-Saharan Africa: a systematic review. HPB (Oxford). 2024;26(1):21\u201333. https:\/\/doi.org\/10.1016\/j.hpb.2023.09.015.\u00a0Epub 2023 Sep 22. PMID: 37805364.","journal-title":"HPB (Oxford)"},{"issue":"7","key":"4946_CR30","doi-asserted-by":"publisher","first-page":"e312","DOI":"10.1016\/S1470-2045(23)00186-9","volume":"24","author":"A Vitale","year":"2023","unstructured":"Vitale A, Cabibbo G, Iavarone M, Vigano L, Pinato DJ, Ponziani FR, et al. Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept. Lancet Oncol. 2023;24(7):e312\u201322. Epub 2023 July 7.","journal-title":"Lancet Oncol"}],"container-title":["BMC Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12876-026-04946-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12876-026-04946-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T01:29:00Z","timestamp":1784510940000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12876-026-04946-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,25]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4946"],"URL":"https:\/\/doi.org\/10.1186\/s12876-026-04946-8","relation":{},"ISSN":["1471-230X"],"issn-type":[{"value":"1471-230X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,25]]},"assertion":[{"value":"7 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The study proposal was approved by the Department of Surgery Research and Publication Committee, and ethical clearance was obtained from the IRB of the College of Health Sciences, Addis Ababa University and SPHMMC. Written informed consent was taken from the participate and the study adhered with Declaration of Helsinki.In addition, permission was obtained from the hospital to collect the required data. Written informed consent was obtained from the participants. The data were kept confidential and anonymous and were used only for research purposes. The confidentiality of the study participants\u2019 related data was maintained by avoiding possible identifiers such as the name of the patients. Only the identification number was used as a reference.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","label":"Consent for publication","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"458"}}